|
RAD18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.328100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.076800E-01 |
| Normal-vs-Stage2 |
5.815800E-01 |
| Normal-vs-Stage3 |
7.933900E-02 |
| Normal-vs-Stage4 |
7.462200E-01 |
| Stage1-vs-Stage2 |
8.866400E-01 |
| Stage1-vs-Stage3 |
1.388610E-01 |
| Stage1-vs-Stage4 |
9.583400E-01 |
| Stage2-vs-Stage3 |
3.364200E-01 |
| Stage2-vs-Stage4 |
8.785000E-01 |
| Stage3-vs-Stage4 |
3.605800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.203600E-02 |
| Normal-vs-AfricanAmerican |
5.329400E-01 |
| Normal-vs-Asian |
4.905800E-01 |
| Caucasian-vs-AfricanAmerican |
4.051000E-01 |
| Caucasian-vs-Asian |
9.150400E-01 |
| AfricanAmerican-vs-Asian |
8.396000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.411200E-01 |
| Normal-vs-Female |
7.86870000000217E-05 |
| Male-vs-Female |
2.16159999999466E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.390400E-01 |
| Normal-vs-Extreme_Weight |
5.759200E-01 |
| Normal-vs-Obese |
3.188000E-02 |
| Normal-vs-Extreme_Obese |
6.075600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.055600E-01 |
| Normal_Weight-vs-Obese |
1.356980E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.532200E-01 |
| Extreme_Weight-vs-Obese |
6.081000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.967200E-01 |
| Obese-vs-Extreme_Obese |
1.833790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.140100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.124380E-01 |
| Normal-vs-Age(61-80Yrs) |
3.184600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.427000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.366990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.631800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.894200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.341800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.209800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.812000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.188000E-01 |
| Normal-VS-Type2 PRCC |
4.068200E-01 |
| Normal-VS-KIRP CIMP |
1.194300E-02 |
| Normal-VS-Unclassified PRCC |
4.641800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.573000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.392170E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.831700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.767630E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.230430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.296100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.399800E-01 |
| Normal-vs-N1 |
1.948200E-02 |
| Normal-vs-N2 |
7.057400E-01 |
| N0-vs-N1 |
1.492110E-02 |
| N0-vs-N2 |
7.010400E-01 |
| N1-vs-N2 |
3.963400E-01 |
|
|
